Pfizer selects once-daily GLP-1 for its obesity push Pfizer is advancing on a broad front in its attempt to catch up with Novo Nordisk and Eli Lilly in the obesity drug category but has now decided on a lead candidate
WHO Decision Recognizing Obesity as a Disease Treatable with GLP-1 Drugs Is Big Deal, says BU Endocrinologist New guidelines will help reduce stigma around weight management, Ivania Rizo says WHO Decision Recognizing Obesity as a Disease Treatable with GLP-1 Drugs Is Big Deal, says BU Endocrinologist New guidelines will help reduce stigma around weight management, Ivania Rizo says The World Health Organizations new guidelines recognizing obesity as a disease and suggesting that GLP-1 drugs be part of long-term treatment could have wide-ranging benefits, says Ivania Rizo, a Boston University endocrinologist whose research interests center on obesity, diabetes, and metabolic disorders
This disconnect occurs because folate transport across the blood-brain barrier is impaired
Refrigeration doesn't stop these processes entirely, but it slows them down dramatically
Food and Drug Administration: information on compounded GLP-1 drugs and shortage status - See your options in about 2 minutes Take the free quiz and see what fits you
Answer a few questions to get a customized peptide recommendation based on your goals and health profile Answer a few questions for a personalized peptide recommendation based on your goals + health profile
